Aprepitant/Fosaprepitant Dimeglumine and Perflutren lipid microsphere Intravenous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Perflutren lipid microsphere Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Perflutren Lipid Microspheres
- Aprepitant/Fosaprepitant Dimeglumine-Perflutren Protein Type A
- Aprepitant/Fosaprepitant Dimeglumine-Perflutren protein type a microsphere Intravenous
- Aprepitant/Fosaprepitant Dimeglumine-Perforomist
- Aprepitant/Fosaprepitant Dimeglumine-Perforomist, Symbicort
- Aprepitant/Fosaprepitant Dimeglumine-Pergolide
- Perflutren lipid microsphere Intravenous-Apresazide
- Perflutren lipid microsphere Intravenous-Apresoline
- Perflutren lipid microsphere Intravenous-Apresoline Injection
- Perflutren lipid microsphere Intravenous-Apri
- Perflutren lipid microsphere Intravenous-Apriso
- Perflutren lipid microsphere Intravenous-Aprizio Pak